{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:46:48Z","timestamp":1772830008544,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC3501305"],"award-info":[{"award-number":["2022YFC3501305"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC3501305"],"award-info":[{"award-number":["2022YFC3501305"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC3501305"],"award-info":[{"award-number":["2022YFC3501305"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC3501305"],"award-info":[{"award-number":["2022YFC3501305"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC3501305"],"award-info":[{"award-number":["2022YFC3501305"]}]},{"name":"The Seventh Batch of Jilin Province Youth Science and Technology Talent Support Project","award":["QT202314"],"award-info":[{"award-number":["QT202314"]}]},{"name":"The Seventh Batch of Jilin Province Youth Science and Technology Talent Support Project","award":["QT202314"],"award-info":[{"award-number":["QT202314"]}]},{"name":"The Seventh Batch of Jilin Province Youth Science and Technology Talent Support Project","award":["QT202314"],"award-info":[{"award-number":["QT202314"]}]},{"name":"The Seventh Batch of Jilin Province Youth Science and Technology Talent Support Project","award":["QT202314"],"award-info":[{"award-number":["QT202314"]}]},{"name":"The Seventh Batch of Jilin Province Youth Science and Technology Talent Support Project","award":["QT202314"],"award-info":[{"award-number":["QT202314"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04143-1","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T04:48:26Z","timestamp":1735274906000},"page":"24-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"88","author":[{"given":"Tianrui","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianye","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"issue":"1","key":"4143_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"N.E. Gilhus, S. Tzartos, A. Evoli, J. Palace, T.M. Burns, J. Verschuuren, Myasthenia gravis. Nat. Rev. Dis. Prim. 5(1), 30 (2019)","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"26","key":"4143_CR2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"N.E. Gilhus, Myasthenia gravis. N. Engl. J. Med. 375(26), 2570\u20132581 (2016)","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"4143_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.2023.16872","volume":"331","author":"R Marcus","year":"2024","unstructured":"R. Marcus, What is myasthenia gravis? JAMA 331(5), 452 (2024)","journal-title":"JAMA"},{"key":"4143_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"A.S. Carr, C.R. Cardwell, P.O. McCarron, J. McConville, A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 10, 46 (2010)","journal-title":"BMC Neurol."},{"issue":"8","key":"4143_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40265-022-01726-y","volume":"82","author":"D Menon","year":"2022","unstructured":"D. Menon, V. Bril, Pharmacotherapy of generalized myasthenia gravis with special emphasis on newer biologicals. Drugs 82(8), 865\u2013887 (2022)","journal-title":"Drugs"},{"issue":"10","key":"4143_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"N.E. Gilhus, J.J. Verschuuren, Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 14(10), 1023\u20131036 (2015)","journal-title":"Lancet Neurol."},{"issue":"2","key":"4143_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diabres.2015.02.010","volume":"108","author":"T Katsuyama","year":"2015","unstructured":"T. Katsuyama, K.E. Sada, S. Namba, H. Watanabe, E. Katsuyama, T. Yamanari et al. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diab. Res. Clin. Pr. 108(2), 273\u2013279 (2015)","journal-title":"Diab. Res. Clin. Pr."},{"issue":"2","key":"4143_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/dmrr.2486","volume":"30","author":"JL Hwang","year":"2014","unstructured":"J.L. Hwang, R.E. Weiss, Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diab. Metab. Res. Rev. 30(2), 96\u2013102 (2014)","journal-title":"Diab. Metab. Res. Rev."},{"issue":"3","key":"4143_CR9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/mus.21072","volume":"38","author":"E de Sousa","year":"2008","unstructured":"E. de Sousa, J. Howard, More evidence for the association between statins and myasthenia gravis. Muscle Nerve 38(3), 1085\u20131086 (2008)","journal-title":"Muscle Nerve"},{"issue":"7","key":"4143_CR10","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/jcm10071537","volume":"10","author":"S Sheikh","year":"2021","unstructured":"S. Sheikh, U. Alvi, B. Soliven, K. Rezania, Drugs that induce or cause deterioration of myasthenia gravis: an update. J. Clin. Med. 10(7), 1537 (2021)","journal-title":"J. Clin. Med."},{"key":"4143_CR11","doi-asserted-by":"publisher","first-page":"1223322","DOI":"10.3389\/fimmu.2023.1223322","volume":"14","author":"Y Zhu","year":"2023","unstructured":"Y. Zhu, B. Wang, Y. Hao, R. Zhu, Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Front. Immunol. 14, 1223322 (2023)","journal-title":"Front. Immunol."},{"issue":"6","key":"4143_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","volume":"48","author":"A Nacu","year":"2015","unstructured":"A. Nacu, J.B. Andersen, V. Lisnic, J.F. Owe, N.E. Gilhus, Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 48(6), 362\u2013368 (2015)","journal-title":"Autoimmunity"},{"issue":"1","key":"4143_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","volume":"120","author":"UK Misra","year":"2020","unstructured":"U.K. Misra, J. Kalita, V.K. Singh, S. Kumar, A study of comorbidities in myasthenia gravis. Acta Neurol. Belg. 120(1), 59\u201364 (2020)","journal-title":"Acta Neurol. Belg."},{"issue":"8","key":"4143_CR14","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s10072-023-06750-8","volume":"44","author":"HN Ozdemir","year":"2023","unstructured":"H.N. Ozdemir, H. Karasoy, A.N. Yuceyar, O. Ekmekci, Effects of comorbid diseases on clinical outcomes in patients with myasthenia gravis. Neurol. Sci. 44(8), 2923\u20132931 (2023)","journal-title":"Neurol. Sci."},{"key":"4143_CR15","first-page":"3109119","volume":"18","author":"H Sun","year":"2022","unstructured":"H. Sun, P. Saeedi, S. Karuranga, M. Pinkepank, K. Ogurtsova, B.B. Duncan et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diab. Res. Clin. Pr. 18, 3109119 (2022)","journal-title":"Diab. Res. Clin. Pr."},{"issue":"8","key":"4143_CR16","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/jcm13082273","volume":"13","author":"CG Croitoru","year":"2024","unstructured":"C.G. Croitoru, M. Pavel-Tanasa, D.I. Cuciureanu, D.N. Hodorog, P. Cianga, Autoimmune and non-autoimmune comorbidities in myasthenic patients of East-European Descent: a case-control study. J. Clin. Med. 13(8), 2273 (2024)","journal-title":"J. Clin. Med."},{"key":"4143_CR17","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372, n71 (2021)","journal-title":"Bmj"},{"issue":"9","key":"4143_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9), 603\u2013605 (2010)","journal-title":"Eur. J. Epidemiol."},{"key":"4143_CR19","unstructured":"A D.C. Rostom, A. Cranney, et al. Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep. (Evidence Reports\/Technology Assessments, No. 104.) Appendix D. Quality Assessment Forms. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK35156\/."},{"issue":"4","key":"4143_CR20","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s10072-023-07163-3","volume":"45","author":"K Li","year":"2024","unstructured":"K. Li, Y. Ouyang, H. Yang, Myasthenia gravis and five autoimmune diseases: a bidirectional Mendelian randomization study. Neurol. Sci. 45(4), 1699\u20131706 (2024)","journal-title":"Neurol. Sci."},{"issue":"10","key":"4143_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102368","volume":"18","author":"RH Song","year":"2019","unstructured":"R.H. Song, Q.M. Yao, B. Wang, Q. Li, X. Jia, J.A. Zhang, Thyroid disorders in patients with myasthenia gravis: a systematic review and meta-analysis. Autoimmun. Rev. 18(10), 102368 (2019)","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"4143_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/00207454.2022.2031183","volume":"133","author":"X Zhou","year":"2023","unstructured":"X. Zhou, S. Cao, J. Hou, T. Gui, F. Zhu, Q. Xue, Association between myasthenia gravis and cognitive disorders: a PRISMA-compliant meta-analysis. Int. J. Neurosci. 133(9), 987\u2013998 (2023)","journal-title":"Int. J. Neurosci."},{"issue":"10","key":"4143_CR23","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00198-024-07097-2","volume":"35","author":"CJ Lin","year":"2024","unstructured":"C.J. Lin, Y.S. Lee, J.H. Yeh, S.J. Liu, K.Y. Lin, The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis. Osteoporos. Int. 35(10), 1709\u20131717 (2024)","journal-title":"Osteoporos. Int."},{"issue":"3","key":"4143_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00408-021-00444-8","volume":"199","author":"P Yingchoncharoen","year":"2021","unstructured":"P. Yingchoncharoen, N. Charoenngam, B. Ponvilawan, J. Thongpiya, T. Chaikijurajai, P. Ungprasert, The association between asthma and risk of myasthenia gravis: a systematic review and meta-analysis. Lung 199(3), 273\u2013280 (2021)","journal-title":"Lung"},{"issue":"1","key":"4143_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2840","volume":"13","author":"J Nadali","year":"2023","unstructured":"J. Nadali, N. Ghavampour, F. Beiranvand, M. Maleki Takhtegahi, M.E. Heidari, S. Salarvand et al. Prevalence of depression and anxiety among myasthenia gravis (MG) patients: a systematic review and meta-analysis. Brain Behav. 13(1), e2840 (2023)","journal-title":"Brain Behav."},{"issue":"1","key":"4143_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16100","volume":"31","author":"L O\u2019Connor","year":"2024","unstructured":"L. O\u2019Connor, C. Malmestr\u00f6m, R. Da Silva Rodrigues, S. Brauner, A.K. Wikstr\u00f6m, A.R. Punga, Pregnancy outcomes for women with myasthenia gravis and their newborns: a nationwide register-based cohort study. Eur. J. Neurol. 31(1), e16100 (2024)","journal-title":"Eur. J. Neurol."},{"key":"4143_CR27","doi-asserted-by":"publisher","first-page":"1216595","DOI":"10.3389\/fneur.2023.1216595","volume":"14","author":"SP Shen","year":"2023","unstructured":"S.P. Shen, K.J. Herr, Y. Liu, C.C. Yang, C.H. Tang, Healthcare resource utilization and costs associated with generalized myasthenia gravis: a retrospective matched cohort study using the National Health Insurance Research Database in Taiwan. Front. Neurol. 14, 1216595 (2023)","journal-title":"Front. Neurol."},{"key":"4143_CR28","doi-asserted-by":"publisher","first-page":"1203679","DOI":"10.3389\/fneur.2023.1203679","volume":"14","author":"KJ Herr","year":"2023","unstructured":"K.J. Herr, S.P. Shen, Y. Liu, C.C. Yang, C.H. Tang, The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan. Front. Neurol. 14, 1203679 (2023)","journal-title":"Front. Neurol."},{"issue":"1","key":"4143_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02692-4","volume":"22","author":"L Harris","year":"2022","unstructured":"L. Harris, S. Graham, S. MacLachlan, A. Exuzides, S. Jacob, A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis. BMC Neurol. 22(1), 172 (2022)","journal-title":"BMC Neurol."},{"issue":"5","key":"4143_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/ane.13596","volume":"145","author":"JS Park","year":"2022","unstructured":"J.S. Park, K.Y. Eah, J.M. Park, Epidemiological profile of myasthenia gravis in South Korea using the national health insurance database. Acta Neurol. Scand. 145(5), 633\u2013640 (2022)","journal-title":"Acta Neurol. Scand."},{"issue":"8","key":"4143_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1515\/jpm-2020-0163","volume":"48","author":"L Nicholls-Dempsey","year":"2020","unstructured":"L. Nicholls-Dempsey, N. Czuzoj-Shulman, H.A. Abenhaim, Maternal and neonatal outcomes among pregnant women with myasthenia gravis. J. Perinat. Med. 48(8), 793\u2013798 (2020)","journal-title":"J. Perinat. Med."},{"key":"4143_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fpsyt.2019.00481","volume":"10","author":"HT Chu","year":"2019","unstructured":"H.T. Chu, C.C. Tseng, C.S. Liang, T.C. Yeh, L.Y. Hu, A.C. Yang et al. Risk of depressive disorders following myasthenia gravis: a nationwide population-based retrospective cohort study. Front. Psychiatry 10, 481 (2019)","journal-title":"Front. Psychiatry"},{"issue":"2","key":"4143_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/ane.12374","volume":"132","author":"JH Yeh","year":"2015","unstructured":"J.H. Yeh, H.J. Chen, C.C. Lin, Y.K. Chen, H.C. Chiu, C.H. Kao, Risk of diabetes mellitus among patients with myasthenia gravis. Acta Neurol. Scand. 132(2), 132\u2013138 (2015)","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"4143_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/joim.12310","volume":"277","author":"F Fang","year":"2015","unstructured":"F. Fang, O. Sveinsson, G. Thormar, M. Granqvist, J. Askling, I.E. Lundberg et al. The autoimmune spectrum of myasthenia gravis: a Swedish population-based study. J. Intern. Med. 277(5), 594\u2013604 (2015)","journal-title":"J. Intern. Med."},{"issue":"21","key":"4143_CR35","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1097\/MD.0000000000000835","volume":"94","author":"JH Yeh","year":"2015","unstructured":"J.H. Yeh, H.T. Kuo, H.J. Chen, Y.K. Chen, H.C. Chiu, C.H. Kao, Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study. Medicine 94(21), e835 (2015)","journal-title":"Medicine"},{"key":"4143_CR36","doi-asserted-by":"publisher","first-page":"1125842","DOI":"10.3389\/fneur.2023.1125842","volume":"14","author":"YD Liu","year":"2023","unstructured":"Y.D. Liu, F. Tang, X.L. Li, Y.F. Liu, P. Zhang, C.L. Yang et al. Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study. Front. Neurol. 14, 1125842 (2023)","journal-title":"Front. Neurol."},{"issue":"6","key":"4143_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13641","volume":"88","author":"Q Zhou","year":"2022","unstructured":"Q. Zhou, W. Yin, J. Zhu, W. Duan, Y. Li, W. Jin, H. Yang, Risk factors associated with adverse pregnancy outcomes and postpartum exacerbation in women with myasthenia gravis. Am. J. Reprod. Immunol. 88(6), e13641 (2022)","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"4143_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/ane.13549","volume":"145","author":"E Klimiec-Moskal","year":"2022","unstructured":"E. Klimiec-Moskal, M. Quirke, M.I. Leite, Comorbidities in older patients with myasthenia gravis - comparison between early- and late-onset disease. Acta Neurol. Scand. 145(3), 371\u2013374 (2022)","journal-title":"Acta Neurol. Scand."},{"issue":"9","key":"4143_CR39","first-page":"478","volume":"24","author":"S Ruan","year":"2022","unstructured":"S. Ruan, L. Di, Y. Wang, L. Fan, Survey and analysis of the awareness and application status of drugs used with caution in myasthenia gravis patients. [Chinese]. Advers. Drug React. J. 24(9), 478\u2013483 (2022)","journal-title":"Advers. Drug React. J."},{"issue":"12","key":"4143_CR40","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.1007\/s10072-022-06379-z","volume":"43","author":"M Zdraljevic","year":"2022","unstructured":"M. Zdraljevic, S. Peric, M. Jeremic, D. Lavrnic, I. Basta, L. Hajdukovic et al. Myasthenia gravis treated in the neurology intensive care unit: a 14-year single-centre experience. Neurol. Sci. 43(12), 6909\u20136918 (2022)","journal-title":"Neurol. Sci."},{"issue":"4","key":"4143_CR41","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/mus.27369","volume":"64","author":"J Vijayan","year":"2021","unstructured":"J. Vijayan, D. Menon, C. Barnett, H. Katzberg, L.E. Lovblom, V. Bril, Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis. Muscle Nerve 64(4), 462\u2013466 (2021)","journal-title":"Muscle Nerve"},{"key":"4143_CR42","doi-asserted-by":"crossref","unstructured":"J.D. Parada-Garza., L.A. Miranda-Garc\u00eda, J.D.J. Gonz\u00e1lez-Jaime, A. Jim\u00e9nez-Ruiz, G. Garc\u00eda-Almeida, G. L\u00f3pez-Valencia, et al. Myasthenia gravis in a reference Western Mexican Hospital: comparison of a new cohort versus a historical one. Rev. Mex. Neurocienc. 21(5) (2020).","DOI":"10.24875\/RMN.20000145"},{"issue":"3","key":"4143_CR43","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3889\/oamjms.2018.110","volume":"6","author":"N Tanovska","year":"2018","unstructured":"N. Tanovska, G. Novotni, S. Sazdova-Burneska, I. Kuzmanovski, B. Boshkovski, G. Kondov et al. Myasthenia gravis and associated diseases. Open Access Maced. J. Med. Sci. 6(3), 472\u2013478 (2018)","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"1","key":"4143_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/01616412.2018.1525121","volume":"41","author":"L Fan","year":"2018","unstructured":"L. Fan, S. Ma, Y. Yang, Z. Yan, J. Li, Z. Li, Clinical differences of early and late-onset myasthenia gravis in 985 patients. Neurol. Res. 41(1), 45\u201351 (2018)","journal-title":"Neurol. Res."},{"key":"4143_CR45","unstructured":"S.R Sudulagunta, M Sepehrar, M.B Sodalagunta, A Settikere Nataraju, S.K Bangalore Raja, D. Sathyanarayana, et al. Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab. Ger. Med. Sci. 14, Doc12 (2016)."},{"issue":"10","key":"4143_CR46","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00415-012-6478-6","volume":"259","author":"SA \u017divkovi\u0107","year":"2012","unstructured":"S.A. \u017divkovi\u0107, P.R. Clemens, D. Lacomis, Characteristics of late-onset myasthenia gravis. J. Neurol. 259(10), 2167\u20132171 (2012)","journal-title":"J. Neurol."},{"issue":"2","key":"4143_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-0404.2006.00649.x","volume":"114","author":"C Toth","year":"2006","unstructured":"C. Toth, D. McDonald, J. Oger, K. Brownell, Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol. Scand. 114(2), 124\u2013132 (2006)","journal-title":"Acta Neurol. Scand."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04143-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T07:05:41Z","timestamp":1743231941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04143-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["4143"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04143-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}